Correlation Between Unicycive Therapeutics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Unicycive Therapeutics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Pasithea Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Pasithea Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Pasithea is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Pasithea Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.99 times more return on investment than Pasithea Therapeutics. However, Unicycive Therapeutics is 1.01 times less risky than Pasithea Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.03 per unit of risk. If you would invest 78.00 in Unicycive Therapeutics on September 5, 2024 and sell it today you would lose (7.00) from holding Unicycive Therapeutics or give up 8.97% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Unicycive Therapeutics |
| Pasithea Therapeutics |
Unicycive Therapeutics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Pasithea Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Pasithea Therapeutics vs. Candel Therapeutics | Pasithea Therapeutics vs. Cingulate Warrants | Pasithea Therapeutics vs. Unicycive Therapeutics | Pasithea Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |